Arrayit Corporation (ARYC)

[BBstocks77]

ARYC Potential revenue streams partial list and a list of recent prs at bottom:

List compiled from recent company tweets and prs- https://twitter.com/arrayit

1. USDA:
a. http://www.arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_and_USDA_Expanding_Pat/arrayit_and_usda_expanding_patent_protection_for_food_safety_tes.html

b. Arrayit-USDA food safety test readily detects Listeria monocytogenes implicated in recent food contamination recall freep.com/story/money/bu…
c. Arrayit-USDA miniaturized and multiplexed food safety test can rapidly identify pathogens and increase food safety chicagotribune.com/business/ct-ch…
d. Arrayit-USDA microarray technology food safety test Sensors manuscript published in Google Scholar database mdpi.com/1424-8220/17/9…
e. Arrayit reports $228,000 microarray technology and services lead from top United States Department Agriculture USDA
f. https://www.ars.usda.gov/research/project/?accnNo=430420
g. 1-9-18:Arrayit-USDA food safety team receives speaking invitation to the top international science meeting entitled the 22nd International Conference on Food Processing and Analysis to be held on October 11-13 2018 in Moscow Russia https://foodprocessing.foodtechconferences.org
h. 2-12-18: Arrayit-USDA food safety testing team receives methods video publication invitation from research and science advancement leader JoVE headquartered in Cambridge Massachusetts USA and changing the way science is done https://www.jove.com
i. 2-18-18: Arrayit-USDA Food Safety Microarray Test rapidly and accurately detects the strains of norovirus implicated in the 2018 Winter Olympics in PyeongChang South Korea http://www.foxnews.com/health/2018/02/16/what-is-norovirus-2018-winter-olympics-plagued-by-vomit-inducing-bug.html …
j. Arrayit-USDA Food Safety Team receives publication invitation from Journal of Microbiology and Laboratory Science a top peer-reviewed scholarly journal dedicated to the advancement in all fields of microbiology and lab science http://www.scholarenajournals.com/journals/journal-of-microbiology-and-laboratory-science/jhome.php …
k. Additional USDA Info: https://usdasearch.usda.gov/search?utf8=%E2%9C%93&affiliate=usda&query=arrayit&commit=Search
l. 5-1-18: Arrayit-USDA food safety team receives keynote speaker invitation to the 3rd International Conference on Food & Beverage Packaging being held on July 16-18 2018 in Rome Italy and featuring making life healthier through proper food and beverage packaging https://foodpackaging.conferenceseries.com
m. 6-2-18: Arrayit-USDA food safety testing team strongly recommends "farm to fork" testing of meats, poultry, fruits and vegetables to ensure a safe and healthy food supply for American consumers. Arrayit technology enables rapid, affordable and scaleable testing https://www.bbc.com/news/world-us-canada-44335702 …
n. 7-25-18: Arrayit government contracts team quotes $80,600 microarray life sciences services sale to the top government agency the United States Department of Agriculture USDA headquartered in Washington DC USA and funded by a massive $137,000,000,000 annual budget https://www.usda.gov
o. 8-8-18: Arrayit government contracts team quotes $79,600 microarray life sciences services sale to the prestigious agricultural leaders United States Department of Agriculture USDA headquartered in Washington DC USA and funded by a massive $137 billion 2018 budget https://www.usda.gov



2. FDA:
a. https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?sd=srolist&id=6BDB7EF2A41C9A74E053554DA8C0EDE4&rownum=1

DUNS NUMBER: 962379470

b. Arrayit reports $155,000 microarray platform RFQ from the United States Food and Drug Administration FDA
c. 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov
d. 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov
e. 4-30-18: Arrayit government contracts team quotes $76,500 microarray life sciences instrument sale to a top official at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland and ensuring the safety of the nation's food and drugs https://www.fda.gov
f. 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety https://www.fda.gov
g. 6-19-18: Arrayit CLIA clinical team confirms July 2 2018 meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major microarray product line. The FDA is HQ in Maryland USA and funded by a massive $4.9 billion annual budget https://www.fda.gov
h. 6-27-18: Arrayit CLIA clinical team schedules 7/1 Sunday evening dinner meeting in advance of the 7/2 meeting with top officials at the United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and regulating $1 trillion+ in consumer products https://www.fda.gov
i. 7-2-18: Arrayit CLIA clinical team meets with top brass at the United States Food and Drug Administration FDA to discuss FDA approval of a major product line. The FDA is headquartered in Silver Spring Maryland USA and oversees $1 trillion+ in consumer products https://www.fda.gov
j. 7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
k. 7-16-18: 7-16-18: July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD). https://www.marketwatch.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-administration-2018-07-16?siteid=bigcharts&dist=bigcharts
Award ID (Mod#):
75F40118P10123 ( 0 ) (View) Award Type: PURCHASE ORDER
Vendor Name: ARRAYIT CORPORATION Contracting Agency: FOOD AND DRUG ADMINISTRATION
Date Signed: July 09, 2018 Action Obligation: $43,380
Referenced IDV: Contracting Office: FDA OFFICE OF ACQ GRANT SVCS
NAICS (Code): ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING ( 334516 ) PSC (Code): LABORATORY EQUIPMENT AND SUPPLIES ( 6640 )
Vendor City: SUNNYVALE Vendor DUNS: 962379470
Vendor State: CA Vendor ZIP: 940854518
Global Vendor Name: ARRAYIT CORPORATION Global DUNS Number: 962379470
l. 9-24-18: Arrayit new GlobeNewswire press release "Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration" is important because it empowers top FDA scientists with the same technology we use in our CLIA lab https://finance.yahoo.com/news/arrayit-corporation-ships-clinical-instrumentation-093000351.html …

3. DOD:
a. Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD. http://www.defense.gov
b. 8-31-16: Arrayit prepares bid for $4,500,000 blood card kit contract to US Department of Defense DOD https://t.co/0ePvq047Dy
c. 3-16-17: Arrayit manufacturing team completes 800 whole blood card production run for the US Department of Defense.


4. ALLERGY TESTING: Arrayit offers allergy testing through an increasing number of market sub-brands.

http://arrayit.com/Clinical/clinical.html

Arrayit web team adds updates to our allergy testing web page including electronic portal access for doctors and clinics wishing to utilize our finger stick microarray test for allergy testing and our suite of immunotherapy products for allergy treatment (link: http://arrayit.com/Clinical/Allergy_Test/allergy_test.html) arrayit.com/Clinical/Aller…

https://www.patientdatasolutions.com/signup/rs4884/

a. AllergyGo/AllergyPro & Arrayit partnership:

“The services on this website are provided by ARRAYIT CORPORATION, a Nevada corporation (“Arrayit”) and ALLERGYGO, LLC, a Texas limited liability company (“AllergyGo”). Arrayit is in the business of developing and manufacturing certain proprietary life science technologies for disease prevention and treatment, specifically including advanced blood card technology with IgE microarray testing for allergens (“Tests”), and AllergyGo is in the business of marketing and distributing allergy testing products.”
http://allergygo.com/

AllergyPro is the only company to use the same proteins for blood testing, scratch testing and immunotherapy in the world.

https://s3.amazonaws.com/bbemail/PROD/ulib/p5d1n/docs/73d0e7a8-72f3-5203-445b-dfea5f12a989/HMAllergyProSales11.12.16.pdf
AllergyPro/AllergyGo:

Recently updated website:
http://allergygo.com/testing-original-design/

New AllergyPro/AllergyFree website:

https://allergyfree.us/treatment/

New AllergyPro/AllergyFreePets website:

https://allergyfreepets.net/

Arrayit animal companion testing technology:

http://www.arrayit.com/Products/Protein_Microarrays/Pet_Allergy_Testing/pet_allergy_testing.html

AllergyPro/PFDAllergy:

http://www.pfdallergy.com/testing/

“Coming Soon Oral Allergy Immunotherapy Toothpaste Stay tuned!”
http://www.pfdallergy.com/treatment/

AllergyPro/AllergyWorx:

https://www.allergyworx.com/

https://d2jug8yyubo3yl.cloudfront.net/26999B2F-7C10-4962-918C-E964709E745D/725aa3ff-24c4-480e-be4b-e5b0c87c9b3d.pdf

AllergyPro/AllergyWorx

https://m.youtube.com/watch?v=RXQvk6xrrw0

https://www.standardmedicalsystems.com/allergy-worx

AllergyPro improving wellness:

http://www.kimsantiagingandwellnesscenter.com/allergypro

MD AllergyPro:
https://premedinc.com/md-healthpro/

New MD DiabeticPro mentioned.

Nice video by AllergyPro/AllergyGo co-founder:
https://pcmsadvisors.com/home/allergy-testing-services/

https://www.laboratorynetwork.com/doc/new-test-and-treatment-allergy-program-enables-all-physicians-0001

https://pcmsadvisors.com/about/team/md-solutions-allergy-testing/

“PROTECTED: DX SOLUTIONS / ARRAYIT – ALLERGY CHECK TESTING”

AllergyPro NBC News video:
https://www.bing.com/videos/search?q=nbc+allergy+testing+finger+prick&view=detail&mid=59938DB460F007825A6659938DB460F007825A66&FORM=VRRTAP

Additional partnerships?
https://pediatricallergysolutions.com/

https://optimumallergysolutions.com/

Same oral allergy toothpaste that is mentioned as “coming soon” in the PFDAllergy/AllergyPro website?
https://allovate.com/

Allergy121 another market sub-brand?

Arrayit Allergy121 finger stick allergy test measures IgE reactivity to penicillin providing a useful indication for penicillin allergy. Arrayit CLIA clinical team strongly endorses National Penicillin Allergy Day on September 28 2018 to raise awareness (link: https://nationalpenicillinallergyday.com) nationalpenicillinallergyday.com

https://mobile.twitter.com/arrayit/status/1031948179736944640

Anti-Aging & Wellness Center

“AllergyPro is a revolutionary new program to help you live allergy free."

http://www.kimsantiagingandwellnesscenter.com/allergypro

http://allergygo.com/
https://pcmsadvisors.com/about/team/md-solutions-allergy-testing/

http://bluevesselpartners.com/allergypro/

b. Pinnertest
https://pinnertest.com/
https://www.instagram.com/pinnertestusa/

https://mobile.twitter.com/Pinnertest_USA

https://mobile.twitter.com/PinnerTR

Pinnertest utilizes advanced IgG (FC Fragment Specific), Antigen, Antiserum, Control tests to determine an individual’s food sensitivities.

By using this particular kind of test, our lab can thoroughly measure the IgG antibody levels against the proteins of over 200 different foods. This progressive technique works to identify the foods that respond negatively with your system–all with just a few drops of blood dispensed by a basic finger prick.

https://pinnertest.com/frequently-asked-questions/

https://pinnertest.com/order/

https://pinnertest.com/food-sensitivity-test/

https://pinnertest.com/legal-disclaimer/

https://mobile.twitter.com/Pinnertest_USA

5-3-18: Arrayit business development team expands sales and marketing agreement with food sensitivity testing leader Pinnertest headquartered in North Bergen New Jersey USA and improving well-being by harmonizing diet and genetics through personalized proteomics https://pinnertest.com

5-13-18: Arrayit releases new company newsletter featuring our dynamic business-to-business B2B product Pinnertest which is the market's finest consumer test for dietary wellness and food intolerance based finger stick and advanced microarray testing of 202 foods https://pinnertest.com

6-1-18: Arrayit CLIA clinical and bioinformatics teams begin implementation of additional software automation to increase test throughput for our physician-ordered business-to-business Pinner USA blockbuster lifestyle test Pinnertest for greater dietary wellness https://www.amazon.com/Pinnertest-Intolerance-200-Foods-Sensitivity/dp/B07CL6KM8C/ref=sr_1_2_a_it?ie=UTF8&qid=1527867299&sr=8-2&keywords=Pinnertest …


6-15-18: Arrayit CLIA clinical laboratory and Pinner USA expand Pinnertest dietary wellness food intolerance testing to a top clinical laboratory headquartered in Hong Kong and serving the lucrative and rapidly expanding wellness testing markets in South China https://pinnertest.com
6-23-18: Arrayit web design team updates the company home page to more prominently feature our innovative and automated finger stick sampling and blood card collection IgE food and environmental allergy and IgG dietary wellness food intolerance testing services http://arrayit.com
6-25-18: Arrayit new company newsletter features our blockbuster allergy test that measures total immunoglobulin E (IgE) and specific reactivity to 120 food and environmental allergens for the massive $40 billion allergy and asthma testing and therapeutics markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
6-27-18: Arrayit CLIA clinical laboratory reports allergy testing sales opportunity with a leading hospital network headquartered in the Northeastern United States and providing premium healthcare solutions and treatment to an extensive patient network http://arrayit.com/Clinical/clinical.html …
8-21-18: Arrayit Allergy121 finger stick allergy test measures IgE reactivity to penicillin providing a useful indication for penicillin allergy. Arrayit CLIA clinical team strongly endorses National Penicillin Allergy Day on September 28 2018 to raise awareness https://nationalpenicillinallergyday.com
8-29-18: Arrayit CLIA clinical team reports finger stick allergy testing commercialization opportunity with a leading healthcare provider headquartered in Jeddah Saudi Arabia and serving the massive high-growth $20 billion Saudi Arabian health and wellness markets http://arrayit.com/Clinical/clinical.html …
9-10-18: Arrayit business development team signs non-disclosure agreement with the global head of business development and mergers and acquisitions of a major allergy testing company headquartered in the European Union and advancing allergy healthcare globally http://arrayit.com/Clinical/clinical.html …


5. Micro array services:
a. 9-12-2016: Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider. https://twitter.com/arrayit/status/775361066666594304
b. 7-1-16: Arrayit signs $27.1 million term sheet for microarray services with US-based research leader http://arrayit.com/Services/services.html https://twitter.com/arrayit/status/748909205969514496
c. Arrayit microarray services team completes pilot project for top investigator at the world renowned cancer center Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology MIT in Cambridge Massachusetts USA ki.mit.edu
d. From 1-3-18: Arrayit microarray services team quotes $2,500,000 research sale to top proteomics research laboratory headquartered in the Northeastern USA http://arrayit.com/Services/services.html
e. 9-5-18: Arrayit sales and marketing team reports $30,000 microarray life sciences services sale to a leading clinical medicine company headquartered in the Southeastern USA and commercializing finger stick testing products for the lucrative wellness test markets http://arrayit.com/Clinical/clinical.html …
f. 9-11-18: Arrayit government contracts team submits $850,000 microarray service bid to a top government agency studying serum protein biomarkers as indicators of cardiovascular, neurological, metabolic, oncologic and inflammatory conditions in a large patient cohort http://arrayit.com/Clinical/clinical.html …
g. 9-21-18: Arrayit CLIA clinical laboratory completes $77,000 microarray manufacturing run to build inventory for a top biotechnology customer headquartered in the Northeastern USA and focusing on the lucrative high-growth wellness and healthcare testing markets http://arrayit.com/Clinical/clinical.html …

6. Micro array platforms:
a. Arrayit completes site visit with major European life sciences leader regarding sale of 40 microarray platforms arrayit.com/Products/produ…

b. Arrayit patented and proprietary microarray platform featuring miniaturization, parallelism and automation is well-suited for Global In Vitro Diagnostic Market Boom including in vitro diagnostic IVD tests per top analysts Zacks finance.yahoo.com/news/global-vi…
c. Arrayit microarray technology customers include 8 of the world's top 10 pharmaceutical companies with a combined market cap exceeding $1.4 trillion genengnews.com/the-lists/top-…
d. Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception shop.arrayit.com
e. Arrayit proprietary DNA microarray platform well-positioned in the gene expression market which, according to business research leaders MarketsandMarkets™, is expected to reach $5.3 billion by 2020 https://www.marketsandmarkets.com/PressReleases/gene-expression-analysis.asp …
f. 2-27-18: Arrayit sales and marketing team quotes $1,490,000 microarray platform to a top biomedical research laboratory headquartered in the Southern USA and specializing in the analysis of genomic and proteomic biomarkers http://arrayit.com/Microarray_Diagnostics/Diagnostic_Platforms/diagnostic_platforms.html …
g. 2-17-18: Arrayit sales and marketing department quotes $100,700 microarray platform to a top researcher at complex diagnostics and precision medicine leading Bioceryx headquartered in Menlo Park California USA https://www.bioceryx.com
h. 3-21-18: Arrayit sales and marketing team reports $109,500 microarray life sciences platform sale to molecular diagnostics leaders Bioceryx headquartered in Menlo Park California USA and making advances in precision medicine universally accessible to all patients https://www.bioceryx.com
i. 4-20-18: Arrayit sales and marketing team reports $145,000 microarray life sciences platform request from top life science distributor Al Rayyan International headquartered in Amman Jordan and providing premium sales support in the expanding Middle East markets https://www.linkedin.com/in/wassan-al-saffar-617874105/#experience-section …
j. 4-23-18: Arrayit sales and marketing team reports $51,800 microarray life sciences platform exclusive purchasing request from top life sciences distributors Intercovamex headquartered in Cuernavaca Morelos Mexico and serving the biotechnology growth markets http://www.intercovamex.com
k. 4-25-18: Arrayit sales and marketing team provides system documentation information for a $168,000 microarray life sciences platform sale to a top biomedical distributor in the Middle East serving the rapidly expanding research, clinical and biotechnology markets http://arrayit.com/Products/Microarrayers/microarrayers.html …
l. 5-4-18: Arrayit sales and marketing team reports $40,000 microarray life sciences platform request from a top life sciences distributor headquartered in China and focusing on advancing biomedical research using miniaturization and molecular medicine http://arrayit.com/Products/products.html …
m. 5-14-18: Arrayit sales and marketing team completes on-site microarray life sciences platform training in New York City USA for top scientists at a leading cellular therapeutics company headquartered in the Middle East http://arrayit.com/Products/Microarray_Platforms/microarray_platforms.html …
n. 5-14-18: Arrayit engineering team provides technical support regarding $80,000 life sciences platform sale to top life sciences distributor Al Rayyan International Scientific Company headquartered in Amman Jordan and expanding Middle East revenues and earnings http://arrayit.com/Products/products.html …
o. 5-18-18: Arrayit sales and marketing team quotes $127,000 microarray life sciences platform sale to a top scientist at the prestigious University of Wisconsin at Madison headquartered in Madison Wisconsin USA and consistently ranked a top research institution https://www.wisc.edu
p. 6-12-18: Arrayit sales and marketing team reports $138,000 microarray life sciences platform request from top distributor Al Rayyan International Scientific Company headquartered in Amman Jordan and serving the lucrative Middle East clinical testing markets https://www.facebook.com/Al-Rayyan-International-Scientific-Company-1959224747725660/ …
q. 8-9-18: Arrayit sales and marketing team reports $42,000 microarray life sciences platform sales request from top life sciences distributor VF Productions headquartered in Selangor Malaysia and serving the high-growth biotechnology and consumer healthcare markets https://www.vfproductions.biz
r. 8-22-18: Arrayit sales and marketing team quotes $31,000 microarray life sciences platform sale to life sciences distribution leaders Ohio Technologies headquartered in Tamil Nadu India and a key supplier to the massive biotechnology and healthcare markets in India http://ohiotech.in
s. 9-24-18: Arrayit shipping department ships $44,000 microarray platform sale to a leading research and healthcare laboratory headquartered in the United States and applying emerging technology to improve and ensure the performance of commercial testing products http://arrayit.com/Clinical/clinical.html …

7. Diabetes testing:
a. Arrayit microarray services team accelerates biomarker discovery for growing $32 billion diabetes testing market prweb.com/releases/diabe
b. 1-31-18: Arrayit clinical and microarray services teams reports positive project update from top diabetes research and companion diagnostic testing development leader headquartered in the Southern USA http://arrayit.com/Services/services.html …
c. 6-29-18: Arrayit CLIA clinical team receives invitation to the 3rd World Congress on Clinical Trials in Diabetes being held on December 3-4 2018 in Vienna Austria and featuring the top experts in the $31.2 billion global diabetes testing and therapeutics markets http://www.wctd2018.com/default.aspx

8. Parkinsons Disease Test:
a. 1-7-18: Arrayit patented and proprietary microarray-based biomarker discovery program and PDx™ Parkinsons Disease Companion Diagnostic Test can greatly reduce the cost of PD drug discovery by pinpointing molecular pathways in advance of costly clinical trials https://www.wsj.com/articles/pfizer-ends-hunt-for-drugs-to-treat-alzheimers-and-parkinsons-1515267654 …
b. 4-30-18: Arrayit business development team submits $5 million strategic partnering proposal a top therapeutics company discovering and developing next generation drugs to treat Parkinson's Disease and other neurodegenerative illnesses http://arrayit.com/Microarray_Diagnostics/Parkinsons_Disease/parkinsons_disease.html …
c. 8-1-18: Arrayit CLIA clinical pipeline gene expression microarray test for Parkinson's Disease PDx™ is well-positioned in the US healthcare market for PD which is estimated at $25 billion annually by top business research and consulting experts Roots Analysis https://www.rootsanalysis.com/reports/view_document/parkinsons-disease-market-pipeline-review-developer-landscape-and-competitive-insights/203.html …
d. 8-21-18: Arrayit PDx finger stick pipeline test for Parkinson's Disease is well-positioned as a pre-symptomatic companion diagnostic test in the important PD healthcare market estimated at $25 billion annually by top healthcare business analysts Roots Analysis http://arrayit.com/confidential/Parkinsons-Market.pdf …

9. Ovarian cancer test (OvaDx):
Arrayit Corporation has leveraged its proprietary life sciences platform to develop OvaDx®, the first definitive test for early stage detection of ovarian cancer. Arrayit also has pipeline diagnostic tests for Parkinson’s Disease, Plavix®, Male Fertility, and Prostate Cancer. These microarray-based tests will be available to the public upon FDA approval.

http://www.arrayit.com/Microarray_Diagnostics/microarray_diagnostics.html
http://www.arrayit.com/Microarray_Diagnostics/OvaDx_Ovarian_Cancer_Test/ovadx_ovarian_cancer_test.html

Doctors and nurses currently use 15 million CA-125 tests per year to monitor ovarian cancer, generating approximately $2 billion in worldwide revenue. Capturing 1% of the ovarian cancer monitoring market would generate $97.5 million in annual revenues for Arrayit through the manufacture and sale of 150,000 OvaDx® tests at $650 per test. Our Sunnyvale laboratories have more than adequate capacity to process 150,000 OvaDx® tests per year upon FDA approval.

10. ARMY:

a. Arrayit reports prostate cancer test sourcing request from United States Army Medical Center Bethesda Maryland usarmy.com

b. Arrayit reports $1,745,000 microarray services inquiry from top government agency United States Army Medical Center
c. Arrayit reports $84,000 microarray platform sale to http://US.Army ;
Medical Research USAMRIID Frederick MD

11. National Institutes of Health:
a. Arrayit FY2018 revenues and earnings may see positive impact from new $37.1 billion National Institutes of Health NIH budget boosting funding to biomedical research laboratories nationally for basic and targeted healthcare and precision medicine research (link: https://www.genomeweb.com/policy-legislation/congress-boosts-nih-funding-371b-new-spending-bill#.WrP67K2ZPOY) genomeweb.com/policy-legisla…
b. Arrayit submits capabilities statement for major microarray services contract with National Institutes of Health NIH nih.gov
c. 3-21-18: Arrayit sales and marketing team receives $1,050,000 genomics and proteomics pre-solicitation announcement from top government agency National Institutes of Health NIH headquartered in Bethesda Maryland USA and operating with a $31.3 billion annual budget https://www.nih.gov
d. Arrayit government contract team reports $217,000 immunology-based microarray services inquiry from the world leading cancer research center National Cancer Institute NCI headquartered in Bethesda Maryland USA with a $5.3 billion annual operating budget cancer.gov
e. Arrayit government contracts team reports $440,000 sample testing solicitation from the world leader Department of Health and Human Services National Cancer Institute NCI headquartered in Bethesda Maryland USA and supported by a $5.4 billion annual budget (link: https://www.cancer.gov) cancer.gov
f. Arrayit government contracts team quotes $217,400 microarray services sale to the Department of Health and Human Services at the National Institutes of Health NIH headquartered in Bethesda Maryland USA and improving healthcare for the American people (link: https://www.nih.gov) nih.gov
g. 8-17-18: Arrayit revenues and earnings may see positive impact from the new $45.5M National Institutes of Health NIH commitment to fund genome editing technology to improve human health. Arrayit technology enables powerful analysis of the human genome post editing https://www.genomeweb.com/research-funding/nih-commits-455m-fund-genome-editing-technology-projects#.W3bwTa2ZPOY …

12. Veterinary diagnostics market: Arrayit reports positive steps towards entering the rapidly growing $6.7 billion veterinary diagnostics market with companion animal wellness tests that leverage our patented and proprietary microarray technology petproductnews.com/News/Veterinar

a. 2-20-18: Arrayit sales and marketing team reports $10,000 microarray services sale to a leading veterinary medicine company headquartered in the USA and focusing on companion diagnostic testing for the pet market http://arrayit.com/Services/services.html …
b. 6-28-18: Arrayit CLIA clinical team accelerates microarray testing commercialization program with a top biologics provider to address the global pet care markets worth an estimated $202.6 billion annually by 2025 according to top market analysts Grand View Research https://www.prnewswire.com/news-releases/pet-care-market-size-worth-2026-billion-by-2025--cagr-49-grand-view-research-inc-680523541.html …
c. 7-25-18: Manufacturing microarrays for an IgE blood test for dogs. Expanding the use of our technology into vetertinary clinics!
d. 7-26-18: Arrayit CLIA clinical team completes $191,950 canine allergy microarray overnight manufacturing run to commercialize a dog allergy test for the high-growth lucrative $140 billion per year United States companion animal pet food and veterinary care markets https://t.co/TRfj3lWfRd https://t.co/xroJTs4NVR
e. 8-2-18: Arrayit veterinary medicine team demonstrates quantitative immunoglobulin E (IgE) measurements for food and environmental allergy testing in canines to advance commercialization of a dog allergy test for the massive $42 billion US veterinary health market https://www.ibisworld.com/industry-trends/market-research-reports/professional-scientific-technical-services/professional-scientific-technical-services/veterinary-services.html …
f. https://allergyfreepets.net/testing/
g. 8-23-18: Arrayit CLIA clinical laboratory staff and senior management report strategic planning and commercialization conference call this morning with a world leader in veterinary medicine and healthcare http://arrayit.com/Clinical/clinical.html …
h. 8-29-18: Arrayit senior management completes strategic business development conference call with a world leader in veterinary medicine to commercialize "paw stick" microarray tests for canine health and wellness in the rapidly expanding $40 billion US pet markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
i. 9-12-18: Arrayit CLIA clinical team completes $10,000 allergy testing pilot validation study for a top veterinary healthcare company headquartered in the United States and serving the lucrative high-growth $25 billion companion animal and pet healthcare markets http://arrayit.com/Clinical/clinical.html …
j. 10-2-18: Arrayit business development team reports microarray testing earnings and revenues expansion opportunity with a leading veterinary healthcare company headquartered in Chengdu China and serving the massive high growth lifestyle testing markets in East Asia http://arrayit.com/Clinical/clinical.html …
k. 10-22-18: Arrayit CLIA clinical team provides pilot study statistical data analysis for a leading veterinary health company headquartered in the European Union and commercializing products for the lucrative high-growth companion animal healthcare testing markets http://arrayit.com/Clinical/clinical.html …
l. 10-24-18: Arrayit sales and marketing department reports pro forma invoice to the prestigious Indian Veterinary Research Institute headquartered in Bangalore India and serving the lucrative high-growth $5.9 billion Asia-Pacific veterinary health and medicine markets http://ivri.nic.in


13. B2B partners:

a. 1-19-18: Arrayit business development team reports business-to-business B2B opportunity with healthcare leader GE Healthcare Life Sciences a subsidiary of $141.7 billion world industrial and technology leader General Electric NYSE:GE https://www.gelifesciences.com

b. Arrayit business-to-business B2B partner Sensovation Radolfzell Germany introduces new SensoSpot® Microarray Analyzers for multiplex-enabled imaging and automated microarray analysis sensovation.com/sensospot

c. 1-25-18: Arrayit schedules business-to-business B2B site visit today with a large microarray services account headquartered in the Eastern USA http://arrayit.com/Services/services.html …
d. Arrayit reports business-to-business B2B expansion opportunity with medical manufacturing leader Anjue Medical China aj-medical.com
e. Arrayit reports successful business expansion conference call with world antibody production leader Abnova Taiwan abnova.com
f. Arrayit reports business expansion opportunity with leading wellness research center headquartered in Cleveland OH arrayit.com/Services/servi…
g. Arrayit business development team reports business-to-business growth opportunity with platform technology leaders Ionica Sciences headquartered at Cornell University in Ithaca New York USA https://www.ionicasci.com
h. Arrayit business development team receives BioPark speed to market and facilities expansion invitation from world healthcare leader GE Healthcare a subsidiary of $151.2 billion General Electric NYSE:GE https://www.gelifesciences.com/country-selection?originalItemPath=%2fFeHH100Y01S0d027000S1vM …
i. 2-7-18: Arrayit business development team reports business-to-business B2B opportunity with top personal genomics leaders HumanCode combining digital and mobile health with genomics for improved wellness https://www.humancode.com
j. 2-9-18: Arrayit bioinformatics team reports business-to-business B2B opportunity with top business software search leaders Crozdesk headquartered in London United Kingdom and specializing in advanced software discovery https://crozdesk.com
k. 2-20-18: Arrayit microarray services team reports business-to-business B2B manufacturing opportunity with functional proteomics leaders Sengenics headquartered in Cambridge United Kingdom http://www.sengenics.com
l. 3-13-18: Arrayit business development team reports business-to-business B2B opportunity with die casting technology leaders M&K Technologies headquartered in Sunnyvale California USA and serving top customers worldwide http://mnkmfg.com/index.html
m. 4-19-18: Arrayit business development team reports B2B growth opportunity with oncology leader RNCOS Business Consultancy Services providing strategic guidance to top organizations including Roche OTC:RHHBY, Illumina Nasdaq:ILMN and Quest Diagnostics NYSE:DGX https://www.rncos.com
n. 5-21-18: Arrayit business development team reports business-to-business revenues and earnings expansion opportunity with proteome analysis leaders Shantani headquartered in Maharashtra India and enabling discovery of new medicines through innovative technologies http://www.shantani.com/index.php
o. 6-19-18: Arrayit corporate development team reports business expansion opportunity with cGMP and FDA audited human and animal health biologics manufacturing leader VxP Pharma headquartered in Indianapolis Indiana USA and a leading contract research organization CRO https://www.vxpbiologics.com


14. Department of Veterans Affairs:
a. 1-26-18: Arrayit government contracts team prepares molecular testing bid for the Department of Veteran Affairs Network Contracting Office NCO at the GV Sonny Montgomery VA Medical Center headquartered in Jackson Mississippi USA https://www.jackson.va.gov
b. 3-13-18: Arrayit sales and marketing team reports request for information RFI and statement of work SOW for $126,000 microarray services contract from top government agency Department of Veterans Affairs headquartered in Fredericksburg Virginia USA https://www.va.gov
c. 8-20-18: Arrayit CLIA clinical laboratory reports $2,490,000 clinical services sales request from the top government agency the United States Department of Veterans Affairs headquartered in Washington DC USA and providing premium healthcare services to our bravest https://www.va.gov
d. 8-28-18: Arrayit shipping department ships $2,200 microarray life sciences consumables sale to healthcare leading Palo Alto Health Care System headquartered in Palo Alto California USA and providing advanced research and patient care for our cherished veterans https://www.paloalto.va.gov

15. CDC:
a. 8-13-18: Arrayit sales and marketing team reports $43,000 microarray life sciences services sales request from the top government agency the Centers for Disease Control CDC HQ Atlanta Georgia USA and protecting the nation's health with a massive $11 billion budget https://www.cdc.gov
b. 8-22-18: Arrayit sales and marketing team quotes $43,100 microarray life sciences services sale to a top scientist at the top government agency the Centers for Disease Control CDC headquartered in Atlanta Georgia USA and ensuring the public health of all Americans https://www.cdc.gov
c. 9-12-18: Arrayit sales and marketing team reports $71,300 microarray life sciences sales request from the top government agency the Centers for Disease Control CDC headquartered in Atlanta Georgia USA and protecting and ensuring the health and safety of the nation https://www.cdc.gov

16. TELECHEM international is a subsidiary of Arrayit:
https://www.telecheminternational.com/about-us
https://www.telecheminternational.com/about1-c1fmc

a. 12-22-17: Arrayit chemical trading subsidiary TeleChem International Inc reports $8,100 speciality chemical sale to a top industrial supplier headquartered in Arlington Texas https://www.telecheminternational.com
b. 1-23-18: Arrayit chemical trading subsidiary TeleChem International reports chemical synthesis inquiry from the National Center for Advancing Translational Sciences NCATS National Institutes of Health NIH for diagnostic and therapeutic methods and technologies https://ncats.nih.gov
c. 2-2-18: Arrayit chemical trading subsidiary TeleChem International reports $25,000 specialty chemical sale to a top high-end specialty chemical company headquartered in the Western United States and focusing on advanced environmental remediation technology https://www.telecheminternational.com
d. 2-23-18: Arrayit shipping department ships $25,000 specialty chemical sale for our chemical trading subsidiary TeleChem International to a leading environmental remediation company headquartered in the Western USA https://www.telecheminternational.com
e. 3-19-18: Arrayit shipping department ships $16,200 specialty chemical sale to a chemical trading subsidiary TeleChem International customer and top supplier of advanced agricultural products Custom Ag Formulators headquartered in Fresno California USA http://www.customagformulators.com
f. 6-13-18: Arrayit shipping department ships $9,000 specialty chemical sale on behalf of chemical trading subsidiary TeleChem International to a leading distributor headquartered in Arlington Texas USA and a top supplier to the industrial and agricultural sectors https://www.telecheminternational.com
g. 7-6-18: Arrayit accounting department reports $9,000 specialty chemical sales payment from chemical trading subsidiary TeleChem International to a leading specialty chemical provider headquartered in Arlington Texas USA and serving the robust construction markethttps://www.telecheminternational.comc
h. 10-10-18: Arrayit shipping department ships $5,800 specialty chemical sale for chemical-trading subsidiary TeleChem International to Science Applications International Corporation SAIC HQ Fairfield New Jersey USA and strategic supplier to the United States military http://www.saic.com
i. 10-10-18: Arrayit shipping department ships $8,100 specialty chemical sale to a top chemical distribution leader headquartered in Arlington Texas USA and serving the massive and rapidly growing $470 billion industrial and agricultural specialty chemical markets https://www.telecheminternational.com
j. 11-12-18: Arrayit accounting department reports $8,100 specialty chemical sales payment from a top chemical subsidiary TeleChem International customer headquartered in Arlington Texas USA and serving the massive $260 billion industrial and specialty chemical markets https://www.telecheminternational.com
k. 11-15-18: Arrayit sales and marketing team reports $38,700 specialty chemicals purchase request from advanced aerospace leaders Altum Aerospace headquartered in Sunrise Florida USA and a premium supplier to the massive commercial aviation and US defense industries http://altumaerospace.com

17. Avant Diagnostics, Inc.: ARYC also owns 40 million shares of AVDX. https://www.marketwatch.com/story/avant-diagnostics-newly-appointed-president-ceo-philippe-goix-delivered-an-address-to-shareholders-2017-09-27?siteid=bigcharts&dist=bigcharts


18. 1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018 arrayit.com/Products/products.html …

19. Blood collection cards (INCLUDING KAISER DEAL):

a. http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.htm
b. https://m.youtube.com/watch?v=3qANkldK12U

c. 5-13-15: Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. https://finance.yahoo.com/news/arrayit-corporation-vivos-team-global-162100676.html
d. 4-18-16: Arrayit microarray technology team launches whole blood collection card research products.
e. 8-31-16: Arrayit prepares bid for $4,500,000 blood card kit contract to US Department of Defense DOD https://t.co/0ePvq047Dy
f. 3-16-17: Arrayit manufacturing team completes 800 whole blood card production run for the US Department of Defense.
g. 5-11-18: Arrayit prototyping team completes custom whole blood collection card for $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,700,000 members in 8 states https://healthy.kaiserpermanente.org
h. 5-25-18: Arrayit CLIA clinical team completes allergy testing sample collection kits for health maintenance organization (HMO) giant Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare for 11.7 million health plan members (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org
i. 5-31-18: Arrayit CLIA clinical team schedules follow up visit regarding allergy testing with the world's largest health maintenance organization HMO Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,100,000 patients https://healthy.kaiserpermanente.org
j. 6-4-18: Arrayit CLIA clinical team announces technology evaluation including finger stick sampling, blood card collection and microarray wellness testing for allergy and asthma by world healthcare leader Kaiser Permanente headquartered in Oakland California USA https://healthy.kaiserpermanente.org
k. 6-14-18: Arrayit CLIA clinical team submits Client Services Manual to $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare services and care for 11.7 million patients https://healthy.kaiserpermanente.org
l. 10-24-18: Arrayit CLIA clinical team reports scheduled sales visit today to present finger allergy microarray testing to top officials at prestigious Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11.7 million members https://healthy.kaiserpermanente.org

20. Other including additional distributorship opportunities:


a. 1-9-18: Arrayit business development team reports revenue expansion opportunity with small molecule target identification leaders Shantani Proteome Analytics headquartered in Maharashtra India http://www.shantani.com/index.php

b. Arrayit reports positive feedback regarding commercialization opportunity from Columbia Technology Ventures New York techventures.columbia.edu

c. Arrayit reports microarray tech expansion opportunity with largest and strongest eCommerce platform in Japan i-order i-order.asia
d. Arrayit quotes $348,000 annual supply agreement to top wellness testing leader Medica Laboratories Bangkok Thailand http://www.medicalab.co.th
e. Arrayit reports $350,000 microarray services inquiry from leading Veterans Administration Health Care Palo Alto CA
f. Arrayit clinical team completes site visit with clinical experts from a prestigious Northern California hospital and a major governmental approval agency http://arrayit.com/index.html
g. 12-19-17: Arrayit sales and marketing team reports distributorship request from life sciences leaders Elettrofor headquartered in Borsea Italy specializing in research and laboratory instruments and reagents http://www.elettrofor.it/#&panel2-1
h. 1-26-18: Arrayit reports new distributorship and price list request from diagnostic and laboratory research leaders Molgen Biotechnology Lab Supplies headquartered in Istanbul Turkey and specializing in PCR, ELISA, immunohistochemistry, antibodies and consumables http://www.mol-gen.com
i. 1-29-18: Arrayit business development team reports revenue expansion opportunity with top Korean government trade promotion organization Kotra with US offices in Los Angeles and Torrance California USA http://www.kotrala.com
j. 2-9-18: Arrayit sales and marketing team reports new distributor request from life sciences distribution leaders Biosystems headquartered in Sofia Bulgaria and specializing in biochemistry, clinical chemistry and molecular biology http://biosystems.bg
k. 2-7-18: Arrayit sales and marketing team reports global distribution opportunity with marketshare and branding leaders NPI headquartered in Boca Raton Florida USA and operating in the $153 billion health and wellness sector http://nutricompany.com/our-industries/health-wellness/ …
l. 2-20-18: Arrayit sales and marketing team provides 2018 distributor pricing information for our microarray products and services to new distribution partner and life sciences leader Molgen Biotechnology headquartered in Istanbul Turkey http://www.mol-gen.com/en
m. 2-16-18: Arrayit sales and marketing team reports custom microarray manufacturing request from top scientists at world biomedical leader University of Illinois at Urbana-Champaign headquartered in Urbana Illinois USA http://illinois.edu
n. 2-13-18: Arrayit sales and marketing team adds our new distributor Molgen Biotechnology to distributor page accelerating growth of our proprietary microarray life sciences products in the important research and clinical markets in Turkey http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Arrayit_Corporation_Distributo/arrayit_corporation_distributors.html …
o. 2-27-18: Arrayit business develop team submits microarray-based testing proposal to $910 billion consumer goods and electronic equipment giant Apple Nasdaq:AAPL as Apple employee AC Wellness medical clinic sets to open this spring in Santa Clara California USA http://www.foxnews.com/tech/2018/02/27/apple-to-open-ac-wellness-medical-clinics-for-employees.html …
p. 3-6-18: Arrayit business development team reports $500,000 microarray technology opportunity with next generation sequencing and DNA microarray giant $34.7 billion Illumina Nasdaq:ILMN headquartered in San Diego California USA and impacting human health globally https://www.illumina.com
q. 4-25-18: Arrayit business development team completes site visit and revenues expansion meeting with innovation and customization leaders Scientific Device Laboratory headquartered in Des Plaines Illinois USA and serving the research, clinical and industrial markets http://www.scientificdevice.com
r. 4-27-18: Arrayit business development team reports revenues and earnings expansion opportunity with Japanese e-commerce leader Rakuten featuring 25% market share, 45,000 members, 91.5 million Japanese consumers and $27.3 billion annual e-commerce revenue https://www.rakuten.co.jp/ec/sellinjapan/
s. 5-2-18: Arrayit sales and marketing team quotes $183,000 microarray life sciences instrument sale to a top researcher at prestigious McMaster University headquartered in Hamilton Ontario Canada and bringing together the best and brightest minds to better humankind https://www.mcmaster.ca
t. 5-10-18: Arrayit prototyping team manufactures sample parts for $86.0 billion worldwide life science juggernaut Thermo Fisher Scientific NYSE:TMO headquartered in Waltham Massachusetts USA and enabling better healthcare through scientific discovery and innovation https://www.thermofisher.com/us/en/home.html
u. 5-10-18: Arrayit sales and marketing team reports microarray life sciences consumables pricing request from worldwide distribution leaders Interchim headquatered in Montluçon France and serving the rapidly expanding European research and biotechnology markets http://www.interchim.com
v. 5-11-18: Arrayit shipping department ships microarray life sciences consumables sale test parts to $86.6 billion worldwide life science market leader Thermo Fisher Scientific NYSE:TMO headquartered in Waltham Massachusetts USA and leading life sciences innovation https://www.thermofisher.com/us/en/home.html
w. 5-16-18: Arrayit sales and marketing team reports a $134,000 microarray life science services sales request from a leading doctor at the prestigious Center for Neuroscience and Cell Biology headquartered in Coimbra Portugal and a world leader in biomedical research http://www.cnbc.pt
x. 5-21-18: Arrayit clinical team reports microarray technology and test licensing opportunity with the prestigious Columbia Technology Ventures headquartered in New York New York USA and translating research into medical applications for the benefit of society http://techventures.columbia.edu
y. 6-5-18: Arrayit corporate team reports distribution inquiry from a top life sciences and clinical distributor in Beirut Lebanon dedicated to representing major US companies and expanding revenues and earnings in the lucrative Middle East wellness testing markets http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Arrayit_Corporation_Distributo/arrayit_corporation_distributors.html …
z. 6-6-18: Arrayit business development team reports business expansion opportunity with top contract reagent manufacturing leader AmericanBio headquartered in Natick Massachusetts USA and offering premium ISO and cGMP facilities for the biotech and clinical markets https://www.americanbio.com
aa. 6-18-18: Arrayit CLIA clinical team completes $57,750 clinical microarray manufacturing run to expand inventory for a major biotechnology customer leveraging expression analysis in the health and wellness testing sector. Thanks for working on Father's Day everyone! http://arrayit.com/Services/services.html …
bb. 6-18-18: Arrayit marketing team adds top life sciences and medical distributor Al Rayyan International Scientific Company as official Arrayit distributors in Jordan and Turkey to expand sales and revenues in the lucrative Southeast Europe and Middle East markets http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Arrayit_Corporation_Distributo/arrayit_corporation_distributors.html …
cc. 6-20-18: Arrayit reports conference call request from a top buy-side analyst at a leading growth markets intelligence firm headquartered in London United Kingdom and providing buy-side business intelligence for retail investors, institutional investors, asset managers and hedge funds.
dd. 6-22-18: Arrayit marketing team reports new life sciences distributor request from medical distribution leaders HCH Supply headquartered Cairo Egypt and representing $111.6 billion General Electric NYSE:GE and $116.3 billion 3M NYSE:MMM in the lucrative Middle East http://www.hch-supply.com
ee. 6-27-18: Arrayit senior management confirms tomorrow morning conference call to discuss a microarray life sciences sales opportunity with a top five pharmaceutical company providing vital medicines and advanced consumer healthcare products to customers worldwide http://arrayit.com/Products/products.html …
ff. 6-29-18: Arrayit sales and marketing team reports microarray life sciences distribution request from a top medical distribution company headquartered in the Philippines and addressing the lucrative wellness testing markets in the Philippines and Southeast Asia http://arrayit.com/Clinical/clinical.html …
gg. 7-2-18: Arrayit sales and marketing team advances new clinical distributorship discussions with a top medical distributor in the Philippines seeking to promote our wellness testing products and services in the lucrative high-growth Southeast Asia lifestyle markets http://arrayit.com/Clinical/clinical.html …
hh. 7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
ii. 7-5-18: Arrayit sales and marketing team reports microarray life science consumables sales request from top distribution leader Holzel Diagnostics headquartered in Cologne Germany and providing 5,000,000+ products from key suppliers in over 20 countries worldwide https://www.hoelzel-biotech.com/en/
jj. 7-12-18: Arrayit business development team reports business expansion opportunity with a top healthcare distributor headquartered in the Philippines and seeking to address the high-growth lucrative allergy and dietary lifestyle testing markets in Southeast Asia http://arrayit.com/Clinical/clinical.html …
kk. 7-16-18: Arrayit business development team reports allergy clinical testing sales expansion opportunity with a leading medical services company headquartered in Vancouver British Columbia Canada and serving the lucrative $460 billion Canadian healthcare markets http://arrayit.com/Clinical/clinical.html …
ll. 7-16-18: Arrayit business development team reports revenues and earnings growth opportunity with clinical and healthcare distribution leader MarketLab headquartered in Caledonia Michigan USA and a key supplier to the $3 trillion high-growth US healthcare markets https://www.marketlab.com
mm. 7-30-18: Arrayit reports business expansion opportunity with Korean government trade promotion organization KOTRA specializing in providing growth channels for US companies seeking to expand revenues and earnings in the lucrative South Korean consumer marketplaces http://www.kotrala.com
nn. 7-31-18: Arrayit business development team completes conference call with $216.3 billion top global healthcare leader Novartis NYSE:NVS headquartered in Basel Switzerland and providing solutions to address the evolving needs of patients and consumers worldwide https://www.novartis.com
oo. 8-2-18: Arrayit CLIA clinical team reports business expansion opportunity with personalized medicine leader PTM Biosciences headquartered in Caesarea Israel and serving the lucrative high-growth biotechnology and clinical healthcare markets in the Middle East http://www.ptm-biosciences.com
pp. 8-3-18: Arrayit business development team reports business expansion opportunity with precision medicine leader Amplion featuring pre-clinical and clinical biomarker intelligence on tests regulated and approved by the United States Food and Drug Administration FDA http://www.amplion.com
qq. 8-9-18: Arrayit business development team reports revenues and earnings expansion opportunity with a top healthcare company headquartered in Bursa Turkey and serving the rapidly expanding high-growth consumer and lifestyle testing markets in Southeastern Europe http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
rr. 8-9-18: Arrayit CLIA clinical team submits finger stick sampling and blood card collection allergy testing proposal to a top healthcare distributor headquartered in Jeddah Saudi Arabia and serving the lucrative high-growth Middle East consumer healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
ss. 8-13-18: Arrayit business development team reports revenues and earnings expansion opportunity with life sciences leader Eurofins Genomics headquartered in Luxembourg and a top provider of food, environment and pharmaceutical product testing for the global markets https://www.eurofinsgenomics.com/en
tt. 8-15-18: Arrayit business development team reports business partnering opportunity with $3 billion corporate development leaders Partner International headquartered in Highland Park New Jersey USA and providing strategic business growth services for major markets https://partner-intl.com pic.twitter.com/PyIuW7Cskr
uu. 8-23-18: Arrayit sales and marketing team reports $100,000 microarray life sciences instrument sales request from the Program Director at the prestigious Scripps Clinic Medical Group headquartered in La Jolla California USA and providing premium patient health care https://www.scripps.org/medical-groups/scripps-clinic …
vv. 9-13-18: Arrayit business development team reports revenues and earnings growth opportunity with global optical leaders II-VI HQ in Saxonburg Pennsylvania USA and serving the communications, military, life sciences, semiconductor, automotive and consumer markets https://www.ii-vi.com
ww. 9-20-18: Arrayit business development team reports corporate growth proposal from industry leader GeneWorx Capital headquartered in Cambridge Massachusetts USA and offering premium strategic and advisory services to the lucrative high-growth biotechnology sector http://www.geneworxcapital.com
xx. 9-21-18: Arrayit senior management invited to premium institutional investors meeting at the capital markets conference on October 2-3 2018 in London United Kingdom hosted by top investor relations advisory and financial communication services leader Lond Capital https://www.londcapital.com pic.twitter.com/0CrbLLTZyL
yy. 9-26-18: Arrayit sales and marketing team reports $80,300 microarray life sciences instrument sale to life sciences distribution leader Al Rayyan International Scientific HQ in Amman Jordan and serving the lucrative high-growth Middle East lifestyle testing markets https://www.facebook.com/Al-Rayyan-International-Scientific-Company-1959224747725660/ …
zz. 9-27-18: Arrayit CLIA clinical team reports commercialization opportunity with a leading healthcare company headquartered in Jeddah Saudi Arabia and commercializing microarray tests for the lucrative high-growth Middle East clinical and consumer lifestyle markets http://arrayit.com/Clinical/clinical.html …
aaa. 10-11-18: Arrayit production team completes successful supply chain site visit with global instrumentation leader Molecular Devices headquartered in San Jose California USA and operated by $71.6 billion international healthcare leader Danaher Corporation NYSE:DHR http://www.danaher.com
bbb. 10-11-18: Arrayit business development team reports finger stick microarray test commercialization opportunity with a leading medical distribution and marketing company headquartered in Lusaka Zambia and serving the booming $35 billion African healthcare markets http://arrayit.com/Clinical/clinical.html …
ccc. 10-17-18: Arrayit sales and marketing team reports $88,800 microarray life science tools sale to world instrumentation leading Molecular Devices headquartered in San Jose California USA and operated by $73 billion global healthcare giant Danaher Corporation NYSE:DHR http://www.danaher.com
ddd. 10-23-18: Arrayit sales and marketing team reports new distributorship request from biotechnology leader Pearl Biotech headquartered in Ulaanbaatar Mongolia and serving the lucrative high-growth medical research and consumer lifestyle testing markets in East Asia http://pearlbiotech.biz
eee. 10-29-18: Arrayit sales and marketing team reports $26,000 microarray life sciences instrument sales request from a top scientist at the prestigious National Institute for Biotechnology in the Negev HQ in Beer-Sheva Israel and advancing healthcare in the Middle East http://in.bgu.ac.il/en/nibn/Pages/default.aspx …
fff. 10-30-18: Arrayit CLIA clinical team reports business expansion proposal from custom branded specimen collection and transport kits experts Therapak® headquartered in Claremont California USA and serving the massive clinical and consumer healthcare testing markets https://therapak.com
ggg. 11-5-18: Arrayit technical team welcomes Nader G this morning after a long flight from Amman Jordan. Great to have top brass from Al Rayyan Scientific visiting us to tour our amazing Silicon Valley headquarters and discuss expanding business in the Middle East! http://arrayit.com/index.html



RECENT Press Releases and important TWEETS:

5-19-18: Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program. Arrayit's new CLIA license, issued in conjunction with the Department of Health and Human Services (HHS) and the California Department of Public Health (CDPH), provides certification for its Silicon Valley clinical laboratory.
https://www.marketwatch.com/story/arrayit-corporation-announces-new-clinical-licensure-from-the-centers-for-medicare-and-medicaid-services-2018-05-09?siteid=bigcharts&dist=bigcharts

5-21-18: Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists as clinical team aces CAP PT in highly quantitative measurements of IgE using a blinded study protocol. Congratulations to our amazing clinical team!
http://www.globenewswire.com/news-release/2018/05/16/1507332/0/en/Arrayit-Corporation-Scores-100-on-Proficiency-Testing-Conducted-by-the-College-of-American-Pathologists.html

5-30-18: Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for reimbursement under Medicare and Medicaid. Accuracy testing, supervised by the College of American Pathologists (CAP), assesses quantitative measurements of the immunoglobulin E (IgE) regulated analyte in the general immunology proficiency testing program. Arrayit’s testing performance included a score of 100% on the SA-2018 proficiency event and constituted successful cumulative performance required by the Centers for Medicare and Medicaid Services (CMS) over a one-year testing period. CMS regulates approximately 260,000 clinical laboratories through the Clinical Laboratory Improvement Amendments (CLIA) program, and proper certification is required to receive Medicare and Medicaid payments.
https://www.marketwatch.com/story/arrayit-corporation-achieves-testing-accuracy-required-for-medicare-and-medicaid-reimbursement-2018-05-30?siteid=bigcharts&dist=bigcharts

6-18-18: June 18, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives ("sales reps") to sell and distribute the company's allergy tests across the Continental United States, with focus areas in the Pacific Northwest, West, Southwest, Rocky Mountain, Midwest, Northeast and Southeast regions. The network comprises 1,700 sales professionals including 500 sales reps with specific training in finger stick sampling, blood card collection and microarray technology. This extensive professional network will be used to enroll hospitals, health maintenance organizations (HMOs), doctor's and dentist's offices, health clinics and retail stores into the allergy-testing program.
https://www.marketwatch.com/story/arrayit-corporation-announces-nationwide-allergy-testing-sales-and-distribution-network-2018-06-18?siteid=bigcharts&dist=bigcharts

6-29-18: Arrayit signs capital financing agreement with a top buy-side analyst at a leading corporate intelligence firm headquartered in London UK with offices in New York and providing buy-side intelligence to high net worth retail investors, institutional investors and hedge funds.
https://twitter.com/arrayit/status/1012723616373280768

7-2-18: Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and shipped the blood cards to Arrayit for processing. Arrayit processed the specimens and reported 126 quantitative total immunoglobulin E (IgE) measurements and 15,120 allergen-specific determinations indicative of food and environmental allergies. The test results were reviewed and approved by the retail chain’s Chief Medical Officer.
https://www.marketwatch.com/story/arrayit-corporation-completes-allergy-testing-pilot-program-for-one-of-the-nations-largest-retail-chains-2018-07-02?siteid=bigcharts&dist=bigcharts

7-3-18: Arrayit senior management receives NASDAQ and NYSE up-listing proposal from small and mid-cap consulting experts http://uplisting.com focusing on growth companies seeking to improve and enhance shareholder value by listing on a major stock exchange http://www.uplisting.com
https://twitter.com/arrayit/status/1014187818891935744
7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
https://twitter.com/arrayit/status/1014171600051007488
7-8-18: Arrayit web design team updates investor main page and 33 sub-pages including updated information and links regarding Arrayit technology, auditors, biochemistry 101, celebrity spokesperson, CEO, SEC filings, XBRL filings and many other ARYC investor topics http://arrayit.com/Microarray_Investor/microarray_investor.html …
https://twitter.com/arrayit/status/1016023938470576128
7-16-18: July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD).
https://www.marketwatch.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-administration-2018-07-16?siteid=bigcharts&dist=bigcharts

7-25-18: Arrayit senior management completes analyst call with top buy side analyst at the prestigious Alpha Deal Group headquartered in New York NY USA and providing premium independent due diligence for high net-worth retail, instituional and hedge fund customers (link: http://www.alphadealgroup.com) alphadealgroup.com
https://twitter.com/arrayit/status/1022158461302267905

7-30-18: Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, signs allergy testing contracts with a consortium of medical clinics nationwide. The network comprises 178 medical clinics in 29 of the 48 contiguous United States including the Northeast, Southeast, Midwest, South, Southwest, Pacific and Pacific Northwest regions, with single clinics staffing up to 70 physicians. The clinics are using Arrayit allergy testing services to assist physicians in diagnosing and treating allergy and asthma across a wide range of medical specialties and focus areas including anti-aging, back pain and sciatica, chiropractic care, dermatology, digestive health, ear nose and throat (ENT), family medicine, gastroenterology, health and beauty, immunology, integrative medicine, internal medicine, obesity, obstetrics and gynecology (OB-GYN), pain relief, pediatrics, personalized medicine, preventative medicine, primary care, rehabilitation, sinus, spinal care, urgent care, weight loss, wellness and women’s health.
Arrayit recently established a nationwide sales network of 1,700 sales professionals to sell and distribute the company’s finger stick microarray tests to medical clinics and retail chains, completed allergy pilot testing with one the nation’s largest chains of retail stores, met with top officials at the United States Food and Drug Administration (FDA) to discuss FDA approval of a major product line, and reported the sale of clinical instrumentation to the FDA. Arrayit microarray tests conveniently use a few drops of patient blood collected on a blood card to assist doctors in identifying and treating food intolerance, allergy and asthma, and pipeline indications for more serious conditions such as ovarian cancer and Parkinson’s Disease. Doctors can use allergy test results as quantitative tools to inform decisions regarding allergy medicines, immunotherapy, food elimination and lifestyle changes.
https://www.marketwatch.com/press-release/arrayit-corporation-signs-allergy-testing-contracts-with-a-nationwide-consortium-of-medical-clinics-2018-07-30?siteid=bigcharts&dist=bigcharts

8-7-18: Arrayit senior management submits $5,000,000 strategic investment proposal to a companion diagnostics and therapeutics leader headquartered in the San Francisco Bay Area USA and commercializing medicines for the massive $45 billion neurodegenerative market
https://twitter.com/arrayit/status/1026860386782339072

8-13-18: August 13, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer. Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will collect finger stick blood specimens. Two thousand retail locations nationwide averaging 3,000 customer visits per store per day would give Arrayit access to 6 million retail customers daily, creating the potential for exponential sales growth. This promotional campaign required rigorous vetting and high-level corporate approval by the retailer, which reports revenues exceeding $50 billion annually.

https://www.marketwatch.com/press-release/arrayit-corporation-receives-approval-for-in-store-promotions-by-a-major-retail-chain-2018-08-13?siteid=bigcharts&dist=bigcharts

8-27-18: August 27, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutaneous, sublingual, and oral allergy medicines designed to treat patients of allergy and asthma. Allergen immunotherapy, a time-tested clinical approach, can reduce or eliminate allergy and asthma symptoms by lowering the levels of specific cellular proteins known as immunoglobulin E (IgE) molecules that activate the immune system and trigger immune responses. Through these partnerships, doctors prescribing Arrayit allergy tests gain access to a portfolio of safe, effective and convenient allergy medicines for their allergy and asthma patients, including custom immunotherapy products formulated upon review of quantitative allergy test results.
https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-partnerships-with-major-allergy-therapeutics-providers-2018-08-27-51843016?siteid=bigcharts&dist=bigcharts
9-10-18: September 10, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that Arrayit's proprietary finger stick allergy microarray test has been approved for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS). The Medicare national health insurance program provides health insurance to more than 55 million Americans annually, including 46 million seniors and 9 million younger people. CMS projects a 2018 Medicare budget of approximately $705,000,000,000 ($705 billion dollars), representing about 17% of total federal spending.
https://www.marketwatch.com/press-release/arrayit-corporation-approved-for-direct-medicare-billing-by-the-centers-for-medicare-and-medicaid-services-2018-09-10?siteid=bigcharts&dist=bigcharts
9-24-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA). Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ovarian cancer and Parkinson's Disease (PD). Testing is performed in the company's Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the California Department of Public Health (CDPH) and the Center for Medicare and Medicaid Services (CMS).
https://www.marketwatch.com/press-release/arrayit-corporation-ships-clinical-instrumentation-and-software-to-the-united-states-food-and-drug-administration-2018-09-24?siteid=bigcharts&dist=bigcharts
10-8-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen Proficiency Testing (PT) with the College of American Pathologists (CAP). The SC-2017, SA-2018 and SB-2018 triannual CAP Diagnostic Immunology Surveys require highly quantitative measurements of immunoglobulin E (IgE), the antibody molecules measured by the company's finger stick allergy microarray tests. Arrayit's highly accurate PT performance showcases the robustness of the company's proprietary allergy testing platform and reagents, which are increasingly being leveraged by doctors as a tool to diagnose and treat allergy and asthma.
https://www.marketwatch.com/press-release/arrayit-corporation-aces-three-consecutive-rounds-of-proficiency-testing-with-the-college-of-american-pathologists-2018-10-08?siteid=bigcharts&dist=bigcharts
10-22-18: Published: Oct 22, 2018 5:30 a.m. ET
Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, launches a fully automated allergy testing portal for doctors and clinics to streamline and accelerate the allergy testing and treatment process. The Patient Data Solutions (PDS) allergy-testing suite is secure and fully compliant with Health Insurance Portability and Accountability Act (HIPAA) requirements to ensure the privacy of patient health records. The new PDS portal allows doctors to order allergy blood card collection kits, request express mail shipping labels, download allergy test results, and order immunotherapy products from our independent allergy therapeutics partners. The PDS portal, which is free of charge to doctors and clinics, offers continuous, real-time technical assistance to ensure a positive on-line experience.
https://www.marketwatch.com/press-release/arrayit-corporation-launches-patient-data-solutions-allergy-testing-portal-for-doctors-and-clinics-2018-10-22?siteid=bigcharts&dist=bigcharts
10-25-18: Arrayit senior management invited to a top institutional investors conference on November 6-7 2018 in Paris France sponsored by corporate and financial communication services and investment banking leader Lond Capital headquartered in London United Kingdom https://www.londcapital.com
https://twitter.com/arrayit/status/1055490158856794113
10-31-18: Arrayit provides an update to shareholders. We are currently is a quiet period regarding our financials. Our next financial announcement will be the filing of our 10-K and 10-Q forms through 2018. Thanks everyone for your continued support and patience! http://arrayit.com/index.html
https://twitter.com/arrayit/status/1057654833040113665
11-5-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to reach a larger number of allergy patients more quickly. Each brand serving major retail chains, large government agencies, medical clinics and doctor offices receive the same high-level testing support and treatment options through the company's Patient Data Solutions (PDS) on-line allergy testing portal and therapeutics affiliates.
11-9-18: Arrayit senior management invited to top institutional investor meeting the prestigious Capital Markets Conference November 20-21 2018 in Copenhagen Denmark sponsored by Lond Capital HQ London United Kingdom and providing strategic public company guidance https://www.londcapital.com
https://twitter.com/arrayit/status/1060953489969270784
11-12-18: Arrayit manufacturing team expands weekend production and completes a $5.75 million manufacturing run for a top client commercializing finger stick microarray tests for consumer lifestyle and wellness testing in the massive $3.3 trillion healthcare markets http://arrayit.com/Clinical/clinical.html …
https://twitter.com/arrayit/status/1062017703165087744